Literature DB >> 21129364

Etiological heterogeneity in autism spectrum disorders: more than 100 genetic and genomic disorders and still counting.

Catalina Betancur1.   

Abstract

There is increasing evidence that autism spectrum disorders (ASDs) can arise from rare highly penetrant mutations and genomic imbalances. The rare nature of these variants, and the often differing orbits of clinical and research geneticists, can make it difficult to fully appreciate the extent to which we have made progress in understanding the genetic etiology of autism. In fact, there is a persistent view in the autism research community that there are only a modest number of autism loci known. We carried out an exhaustive review of the clinical genetics and research genetics literature in an attempt to collate all genes and recurrent genomic imbalances that have been implicated in the etiology of ASD. We provide data on 103 disease genes and 44 genomic loci reported in subjects with ASD or autistic behavior. These genes and loci have all been causally implicated in intellectual disability, indicating that these two neurodevelopmental disorders share common genetic bases. A genetic overlap between ASD and epilepsy is also apparent in many cases. Taken together, these findings clearly show that autism is not a single clinical entity but a behavioral manifestation of tens or perhaps hundreds of genetic and genomic disorders. Increased recognition of the etiological heterogeneity of ASD will greatly expand the number of target genes for neurobiological investigations and thereby provide additional avenues for the development of pathway-based pharmacotherapy. Finally, the data provide strong support for high-resolution DNA microarrays as well as whole-exome and whole-genome sequencing as critical approaches for identifying the genetic causes of ASDs.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21129364     DOI: 10.1016/j.brainres.2010.11.078

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  373 in total

Review 1.  Networking in autism: leveraging genetic, biomarker and model system findings in the search for new treatments.

Authors:  Jeremy Veenstra-VanderWeele; Randy D Blakely
Journal:  Neuropsychopharmacology       Date:  2011-09-21       Impact factor: 7.853

Review 2.  Oxytocin receptor and Mecp2 308/Y knockout mice exhibit altered expression of autism-related social behaviors.

Authors:  Roger L H Pobbe; Brandon L Pearson; D Caroline Blanchard; Robert J Blanchard
Journal:  Physiol Behav       Date:  2012-03-03

Review 3.  Genetic architectures of psychiatric disorders: the emerging picture and its implications.

Authors:  Patrick F Sullivan; Mark J Daly; Michael O'Donovan
Journal:  Nat Rev Genet       Date:  2012-07-10       Impact factor: 53.242

Review 4.  Translating glutamate: from pathophysiology to treatment.

Authors:  Daniel C Javitt; Darryle Schoepp; Peter W Kalivas; Nora D Volkow; Carlos Zarate; Kalpana Merchant; Mark F Bear; Daniel Umbricht; Mihaly Hajos; William Z Potter; Chi-Ming Lee
Journal:  Sci Transl Med       Date:  2011-09-28       Impact factor: 17.956

5.  Variants in TTC25 affect autistic trait in patients with autism spectrum disorder and general population.

Authors:  Dina Vojinovic; Nathalie Brison; Shahzad Ahmad; Ilse Noens; Irene Pappa; Lennart C Karssen; Henning Tiemeier; Cornelia M van Duijn; Hilde Peeters; Najaf Amin
Journal:  Eur J Hum Genet       Date:  2017-05-17       Impact factor: 4.246

6.  Application of custom-designed oligonucleotide array CGH in 145 patients with autistic spectrum disorders.

Authors:  Barbara Wiśniowiecka-Kowalnik; Monika Kastory-Bronowska; Magdalena Bartnik; Katarzyna Derwińska; Wanda Dymczak-Domini; Dorota Szumbarska; Ewa Ziemka; Krzysztof Szczałuba; Maciej Sykulski; Tomasz Gambin; Anna Gambin; Chad A Shaw; Tadeusz Mazurczak; Ewa Obersztyn; Ewa Bocian; Paweł Stankiewicz
Journal:  Eur J Hum Genet       Date:  2012-10-03       Impact factor: 4.246

7.  Bifenthrin causes transcriptomic alterations in mTOR and ryanodine receptor-dependent signaling and delayed hyperactivity in developing zebrafish (Danio rerio).

Authors:  Daniel F Frank; Galen W Miller; Danielle J Harvey; Susanne M Brander; Juergen Geist; Richard E Connon; Pamela J Lein
Journal:  Aquat Toxicol       Date:  2018-04-18       Impact factor: 4.964

8.  A Statistical Framework for Mapping Risk Genes from De Novo Mutations in Whole-Genome-Sequencing Studies.

Authors:  Yuwen Liu; Yanyu Liang; A Ercument Cicek; Zhongshan Li; Jinchen Li; Rebecca A Muhle; Martina Krenzer; Yue Mei; Yan Wang; Nicholas Knoblauch; Jean Morrison; Siming Zhao; Yi Jiang; Evan Geller; Iuliana Ionita-Laza; Jinyu Wu; Kun Xia; James P Noonan; Zhong Sheng Sun; Xin He
Journal:  Am J Hum Genet       Date:  2018-05-10       Impact factor: 11.025

9.  Physiological arousal in autism and fragile X syndrome: group comparisons and links with pragmatic language.

Authors:  Jessica Klusek; Gary E Martin; Molly Losh
Journal:  Am J Intellect Dev Disabil       Date:  2013-11

10.  Common EIF4E variants modulate risk for autism spectrum disorders in the high-functioning range.

Authors:  Regina Waltes; Johannes Gfesser; Denise Haslinger; Katja Schneider-Momm; Monica Biscaldi; Anette Voran; Christine M Freitag; Andreas G Chiocchetti
Journal:  J Neural Transm (Vienna)       Date:  2014-05-13       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.